Literature DB >> 25396691

Translation of cell therapies to the clinic: characteristics of cell suspensions in large-diameter injection cannulae.

Eduardo M Torres1, Matthieu Trigano, Stephen B Dunnett.   

Abstract

With the use of cell replacement therapies as a realistic prospect for conditions such as Parkinson's and Huntington's diseases, the logistics of the delivery of cell suspensions to deep brain targets is a topic for consideration. Because of the large cannulae required for such procedures, we need to consider the behavior of cell suspensions within the cannulae if we are to ensure that the injected cells are distributed as intended within the target tissue. We have investigated the behavior of primary embryonic cell suspensions of neural tissue, in cannulae of different diameters, using a protocol designed to mimic the handling and injection of cells during clinical application. Internal cannula diameter had a large effect on the distribution of cells during their dispensation from the syringe. In vertical or near vertical cannulae, cells settled toward the tip of the needle, and were dispensed unevenly, with the majority of cells emerging in the first 10-20% of the injectate. In horizontal or near-horizontal cannulae, we observed the opposite effect, such that few cells were dispensed in the first 80% of the injectate, and the majority emerged in the final 10-20%. Use of a glass cannula showed that the results obtained using the horizontal cannula were caused by settling and adherence of the cells on the side of the cannulae, such that during dispensation, the overlying, cell-free solution was dispensed first, prior to the emergence of the cells. We show that the behavior of cells in such cannulae is affected by the cannula diameter, and by the material of the cannula itself. In horizontal cannulae, uneven expulsion of cells from the needle can be ameliorated by regular rotation of the cannula during the procedure. We discuss the potential impact of these observations on the translation of cell therapies to the clinic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25396691     DOI: 10.3727/096368914X685429

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  5 in total

1.  Personalized Needles for Microinjections in the Rodent Brain.

Authors:  Giovanna Paolone; Chiara Falcicchia; Gianluca Verlengia; Mario Barbieri; Anna Binaschi; Federico Paliotto; Beatrice Paradiso; Marie Soukupova; Silvia Zucchini; Michele Simonato
Journal:  J Vis Exp       Date:  2018-01-24       Impact factor: 1.355

Review 2.  Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges.

Authors:  Mahetab H Amer; Felicity R A J Rose; Kevin M Shakesheff; Michel Modo; Lisa J White
Journal:  NPJ Regen Med       Date:  2017-08-10

3.  A biomaterials approach to influence stem cell fate in injectable cell-based therapies.

Authors:  Mahetab H Amer; Felicity R A J Rose; Kevin M Shakesheff; Lisa J White
Journal:  Stem Cell Res Ther       Date:  2018-02-21       Impact factor: 6.832

4.  Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington's disease.

Authors:  Cheney J G Drew; Feras Sharouf; Elizabeth Randell; Lucy Brookes-Howell; Kim Smallman; Bernadette Sewell; Astrid Burrell; Nigel Kirby; Laura Mills; Sophie Precious; Philip Pallmann; David Gillespie; Kerry Hood; Monica Busse; William P Gray; Anne Rosser
Journal:  Brain Commun       Date:  2021-01-19

5.  Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder.

Authors:  Anne E Rosser; Monica E Busse; William P Gray; Romina Aron Badin; Anselme L Perrier; Vicki Wheelock; Emanuele Cozzi; Unai Perpiña Martin; Cristina Salado-Manzano; Laura J Mills; Cheney Drew; Steven A Goldman; Josep M Canals; Leslie M Thompson
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.